Bosh sahifaNWBO • OTCMKTS
add
Northwest Biotherapeutics Inc
Yopilish kursi
0,31 $
Kunlik diapazon
0,30 $ - 0,33 $
Yillik diapazon
0,17 $ - 0,54 $
Bozor kapitalizatsiyasi
425,10 mln USD
Oʻrtacha hajm
5,09 mln
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
OTCMKTS
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 231,00 ming | -48,09% |
Joriy xarajat | 8,21 mln | 0,91% |
Sof foyda | -28,22 mln | -101,92% |
Sof foyda marjasi | -12,22 ming | -288,99% |
Har bir ulushga tushum | — | — |
EBITDA | -18,06 mln | -22,72% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 2,18 mln | 2,30% |
Jami aktivlari | 26,73 mln | -4,08% |
Jami passivlari | 105,71 mln | 41,09% |
Umumiy kapital | -78,98 mln | — |
Tarqatilgan aksiyalar | 1,39 mlrd | — |
Narxi/balansdagi bahosi | -4,40 | — |
Aktivlardan daromad | -165,03% | — |
Kapitaldan daromad | 530,21% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -28,22 mln | -101,92% |
Operatsiyalardan naqd pul | -20,18 mln | -19,01% |
Sarmoyadan naqd pul | -78,00 ming | 81,34% |
Moliyadan naqd pul | 15,94 mln | 10,59% |
Naqd pulning sof oʻzgarishi | -764,00 ming | 80,76% |
Boʻsh pul | -7,97 mln | 23,95% |
Haqida
Northwest Biotherapeutics, Inc. is a development-stage American pharmaceutical company headquartered in Maryland that focuses on developing immunotherapies against different types of cancer. It was founded in 1996 by Alton L. Boynton. Wikipedia
Tashkil etilgan
1-yan, 1998
Sayt
Xodimlar soni
25
